suPAR Michigan M2C2 Heterogeneity Validation Cohort Study

NCT07466524 · clinicaltrials.gov ↗

COMPLETED

Status

367

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Severe Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome

Interventions

DIAGNOSTIC_TEST: suPARnostic® TurbiLatex Assay on Roche cobas c501

Sponsor

ViroGates A/S

Collaborators

[object Object]
[object Object]